Conference item icon

Conference item

89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma

Subtitle:
Conference abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Subgroup:
CRUK/MRC Ox Inst Radiation Oncology
Role:
Author
Publisher:
Society of Nuclear Medicine Publisher's website
Volume:
57
Issue:
S2
Pages:
Article: 333
Publication date:
2016-05-01
EISSN:
2159-662X
ISSN:
0161-5505
Pubs id:
pubs:917722
URN:
uri:84b0b253-661b-48b6-926b-3910c8d715fc
UUID:
uuid:84b0b253-661b-48b6-926b-3910c8d715fc
Local pid:
pubs:917722

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP